Boston, MA -- (SBWIRE) -- 09/28/2016 -- NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.

Technavio's analysts forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.

Get More Details on this Report and a Full Table of Contents at Global Non-Invasive Prenatal Testing Market 2016-2020

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-BGI Genomics
-Illumina
-LifeCodexx
-Natera
-Sequenom

Other prominent vendors

-Ariosa Diagnostics
-Berry Genomics
-CombiMatrix
-F. Hoffmann-La Roche
-Genpharm Services
-Laboratory Corporation of America Holdings
-LifeLabs Genetics
-Quest Diagnostics
-Safembryo
-Sengenics

Market driver

-Incidence of fetal chromosomal disorders in newborns
-For a full, detailed list, view our report

Market challenge

-Limited consumer options and lack of effective product differentiation
-For a full, detailed list, view our report

Market trend

-Increase in partnerships and collaborations
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: BGI Genomics, Illumina, LifeCodexx, Natera, Sequenom, Ariosa Diagnostics, Berry Genomics, CombiMatrix, F. Hoffmann-La Roche, Genpharm Services, Laboratory Corporation of America Holdings, LifeLabs Genetics, Quest Diagnostics, Safembryo, Sengenics.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

-Global Genetic Testing Market 2015-2019
-Global Fecal Occult Testing market 2016-2020
-Global Point-of-Care Coagulation Testing Market 2016-2020
-Global Hospital-acquired Disease Testing Market 2015-2019
-Global Hemoglobin Testing Market 2016-2020